The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule ...

The Inflation Reduction Act was passed in 2021 to reduce the government deficit, incentivize domestic energy production, and ...

The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

New York City-based The Icahn School of Medicine at Mount Sinai has established a new research center focused on using AI to ...

This evolving landscape is tightening its grip on an industry already struggling to keep pace with patient demand, and small molecule drug developers are feeling the pinch most acutely.

WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced ...